U.S. Cardiovascular Device Market Size Worth USD 38.49 Billion by 2034 | CAGR: 5.6%

The U.S. cardiovascular device market size is expected to reach USD 38.49 billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Cardiovascular Device Market Size, Share, Trends, Industry Analysis Report By Device Type (Diagnostic and Monitoring Devices, Therapeutic and Surgical Device), By Application, By End Use – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The U.S. cardiovascular device market refers to the ecosystem of medical technologies designed to diagnose, monitor, and treat various heart-related conditions, including coronary artery disease, arrhythmias, heart failure, and structural abnormalities.

The market continues to expand, driven by a surge in chronic cardiovascular conditions linked to aging populations and lifestyle-induced risk factors. Increasing adoption of minimally invasive surgery has accelerated demand for advanced surgical and interventional tools, particularly stents, catheters, and implantable cardiac devices. Healthcare systems are prioritizing early diagnosis and real-time monitoring, prompting broader usage of wearable cardiac monitors and remote telemetry solutions. Device manufacturers are focusing on smart, data-integrated platforms that allow clinicians to personalize treatment and improve long-term outcomes. Industry trends show strong momentum in AI-driven diagnostics and leadless technologies, which are improving procedural precision and reducing post-operative complications.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/us-cardiovascular-device-market/request-for-sample

Growth in ambulatory surgical settings and outpatient cardiology care creates lucrative opportunities for market players offering compact, portable, and low-maintenance devices tailored to shorter stays and lower costs. Players are leveraging collaborations with health systems and digital health platforms to create holistic cardiovascular care models. Investments in R&D remain high, targeting innovations in bioresorbable materials, wireless communication, and closed-loop monitoring. The shift toward value-based healthcare is also creating space for technologies that deliver both clinical efficacy and economic efficiency. Regulatory support for accelerated approvals of breakthrough cardiac devices is supporting faster commercialization and broader adoption.

Top of Form

Bottom of Form

U.S. Cardiovascular Device Market Report Highlights

• By device type, the therapeutic and surgical devices segment accounted for approximately 70% of the revenue share in 2024, due to the rising number of interventional cardiology procedures across hospitals and specialty cardiac centers.
• By application, the coronary artery disease segment accounted for the largest revenue share in 2024, driven by its widespread prevalence high incidence among aging individuals.
• By end use, the hospitals segment accounted for approximately 60% of the revenue share in 2024, due to their comprehensive infrastructure for handling complex cardiovascular interventions and emergency cardiac care.
• A few key market players are Abbott Laboratories; B. Braun Melsungen AG; Biotronik SE & Co.KG; Boston Scientific Corporation; C. R. Bard, Inc.; Cook Medicals; Lepu Medicals; Liaoning Biomedical Materials; Medtronic Plc; Meril Life Sciences; MicroPort Scientific Corporation; Terumo Corporation; Translumina GmbH; Vascular Concepts; Jude Medical, Inc.; and Edward lifesciences corporation.

Polaris Market Research has segmented the U.S. cardiovascular device market report on the basis of device type, application, end use, and region:

By Device Type (Revenue USD Billion, 2020–2034)

• Diagnostic and Monitoring Devices
  • Electrocardiogram
  • Remote Cardiac Monitoring
  • MRI
  • Others

• Therapeutic and Surgical Devices
  • Ventricular Assist Devices
  • Cardiac Rhythm Management Devices
  • Catheter
  • Stents
  • Others

By Application (Revenue USD Billion, 2020–2034)

• Heart Failure
• Cardiac Arrhythmia
• Coronary Artery Disease
• Others

By End Use (Revenue USD Billion, 2020–2034)

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics